US Patent Issued to INXMED (NANJING) on March 25 for "Use of FAK inhibitor in preparation of drug for treating tumors having NRAS mutation" (Chinese Inventors)

ALEXANDRIA, Va., March 26 -- United States Patent no. 12,257,251, issued on March 25, was assigned to INXMED (NANJING) Co. LTD. (Nanjing, China).

"Use of FAK inhibitor in preparation of drug for treating tumors having NRAS mutation" was invented by Zaiqi Wang (Shanghai), Jiangwei Zhang (Shanghai) and Jun Jiang (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "A use of a FAK inhibitor in the preparation of a drug for preventing and/or treating tumors having an NRAS mutation. A method for treating tumors that have experienced an NRAS mutation, which comprises administering an effective dose of a FAK inhibitor to an individual. A FAK inhibitor for treating tumors having an NRAS mutation. The FAK inhibitor...